Carcinoma de células escamosas de la lengua

Ana Luisa Gallmann; Sofía Carla Juárez; Julieta Roxana Brusa; María Noelia Andrade; María Susana Gómez Zanni; Mariana Beatriz Papa; Mario Luciano Salvano; Andrés Guidi

doi:10.47196/da.v27i3.2191

Authors

Ana Luisa Gallmann Reina Fabiola University Clinic, Cordoba, Argentina
Sofía Carla Juárez Reina Fabiola University Clinic, Cordoba, Argentina
Julieta Roxana Brusa Reina Fabiola University Clinic, Cordoba, Argentina
María Noelia Andrade Reina Fabiola University Clinic, Cordoba, Argentina
María Susana Gómez Zanni Reina Fabiola University Clinic, Cordoba, Argentina
Mariana Beatriz Papa Reina Fabiola University Clinic, Cordoba, Argentina
Mario Luciano Salvano Reina Fabiola University Clinic, Cordoba, Argentina
Andrés Guidi Reina Fabiola University Clinic, Cordoba, Argentina

DOI:

https://doi.org/10.47196/da.v27i3.2191

Keywords:

oral carcinoma, squamous cell carcinoma, verrucous carcinoma

Abstract

Tongue neoplasms are the most common in the oral cavity, and the majority correspond to squamous cell carcinomas. We present two cases of tongue carcinomas, corresponding to moderately differentiated squamous cell carcinoma and verrocus carcinoma, in middle-aged women with oncogenic risk factors. These tumors can have various degrees of differentiation, which determine their prognosis and treatment.

Author Biographies

Ana Luisa Gallmann, Reina Fabiola University Clinic, Cordoba, Argentina

Third Year Resident Physician of Dermatology, Specialist in Internal Medicine, Dermatology Service

Sofía Carla Juárez, Reina Fabiola University Clinic, Cordoba, Argentina

Second Year Resident Physician of Dermatology, Specialist in Internal Medicine, Dermatology Service

Julieta Roxana Brusa, Reina Fabiola University Clinic, Cordoba, Argentina

Fourth Year Resident Physician of Dermatology, Specialist in Internal Medicine, Dermatology Service

María Noelia Andrade, Reina Fabiola University Clinic, Cordoba, Argentina

Medical Specialist in Dermatology and Internal Medicine, Head of Residents, Dermatology Service

María Susana Gómez Zanni, Reina Fabiola University Clinic, Cordoba, Argentina

Medical Specialist in Dermatology and Internal Medicine, Resident Instructor, Dermatology Service

Mariana Beatriz Papa, Reina Fabiola University Clinic, Cordoba, Argentina

Physician, Specialist Professor in Dermatology, Head of the Dermatology Service

Mario Luciano Salvano, Reina Fabiola University Clinic, Cordoba, Argentina

Medical Specialist in Hematology and Internal Medicine, Dermatology Service

Andrés Guidi, Reina Fabiola University Clinic, Cordoba, Argentina

Physician Specialist in Pathological Anatomy, Dermatology Service

References

I. García Kass AI, Domínguez Gordillo AA, García Núñez JA, Cancela Rivas G, et ál. Revisión y puesta al día en cáncer de lengua. Av Odontoestomatol. 2013;29:255-269.

II. Saura E, Jariod ÜM, Simon MV, Gavin M, et ál. Carcinoma escamoso de cavidad oral en paciente menor de edad. Rev Otorrinolaringol Cir Cabeza Cuello. 2017;77:417-424.

III. Allen CM, Camisa C, McNamara KK. Enfermedad oral. En: Bolognia JL. Dermatology. 4.a ed. Barcelona: Elsevier; 2018:1220-1242.

IV. Samman M, Wood H, Conway C, Berri S, et ál. Next-generation sequencing analysis for detecting human papillomavirus in oral verrucous carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol 2014;118:117-125.

V. Wang N, Huang M, Lv H. Head and neck verrucous carcinoma: A population-based analysis of incidence, treatment, and prognosis. Medicine (Baltimore) 2020;99:e18660.

VI. Melo BAC, Vilar LG, de Oliveira NR, Lima PO, et ál. Human papillomavirus infection and oral squamous cell carcinoma - a systematic review. Braz J Otorhinolaryngol. 2021;87:346-352.

VII. Santosh HN, Nagaraj T, Saxena S, Biswas A, et ál. Verrucous carcinoma: A clinicopathological study. J Oral Maxillofac Pathol. 2019;23:303.

VIII. Koyfman SA, Ismaila N, Crook D, D'Cruz A, et ál. Management of the neck in squamous cell carcinoma of the oral cavity and oropharynx: ASCO Clinical Practice Guideline. J Clin Oncol. 2019;37:1753-1774.

IX. Hayes RB, Ahn J, Fan X, Peters BA, et ál. Association of oral microbiome with risk for incident head and neck squamous cell cancer. JAMA Oncol. 2018;4:358-365.

X. Peng Q, Wang Y, Quan H, Li Y, et ál. Oral verrucous carcinoma: from multifactorial etiology to diverse treatment regimens (Review). Int J Oncol. 2016;49:59-73.

XI. FaustinoISP,FernandesDT,Santos-SilvaA,VargasPA,etál.Oral carcinoma development after 23 years of renal transplantation. Autops Case Rep. 2019;9:2019112.

XII. KimYJ,KimJH.Increasingincidenceandimprovingsurvivalof oral tongue squamous cell carcinoma. Sci Rep. 2020;10: 877.

XIII. Hübbers CU, Akgül B. HPV and cancer of the oral cavity. Virulence. 2015;6:244-248.

XIV. Chinn SB, Myers JN. Oral cavity carcinoma: current management, controversies, and future directions. J Clin Oncol. 2015;33:3269-3276.

XV. P ster DG, Spencer S, Adelstein D, Adkins D, et ál. Head and neck cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2020;18:873-898.

XVI. Nair S, Singh B, Pawar PV, Datta S, et ál. Squamous cell carcinoma of tongue and buccal mucosa: clinico-pathologically di erent entities. Eur Arch Otorhinolaryngol. 2016;273:3921-3928. XVII. Hosseinpour S, Mashhadiabbas F, Ahsaie MG. Diagnostic biomarkers in oral verrucous carcinoma: a systematic review. Pathol Oncol Res. 2017;23:19-32.

XVIII. Fuentes Yunes C, Alvarado Suárez R, Aldape Barrios BC. Carcinoma epidermoide de lengua con diagnóstico tardío. Presentación de un caso clínico. Rev Mex Cir Bucal Maxilofac. 2009;5:79-82.

XIX. De Keukeleire S, De Meulenaere A, Deron P, Huvenne W, et ál. Verrucous hyperplasia and verrucous carcinoma in head and neck: use and bene t of methotrexate. Acta Clin Belg. 2020;11:1-5.

XX. Mohan S, Pai SI, Bhattacharyya N. Adjuvant radiotherapy is not supported in patients with verrucous carcinoma of the oral cavity. Laryngoscope. 2017;127:1334-1338.

XXI. Cecchi R, Bartoli L, Brunetti L, Pavesi M. Oral verrucous carcinoma treated with imiquimod 5% cream and carbon dioxide laser. Eur J Dermatol. 2011;21:596-597.